The renin-angiotensin system is activated by short-term, but repressed by long-term growth hormone excess
Clicks: 1
ID: 317696
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #86 of 91 articles by views in european journal of endocrinology
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Background The renin-angiotensin system (RAS) constitutes an important cornerstone in blood pressure (BP) regulation. Previous evidence on the relationship between growth hormone (GH), insulin-like growth factor I (IGF-I), and the RAS is conflicting, depending on study conditions and exposure duration. This exploratory study therefore investigated the effects of short- and long-term GH excess on RAS activity. Methods RAS activity was assessed in 10 healthy, male volunteers (26±5years, BMI 23±3.4kg/m2) before and after one week of daily, subcutaneous GH treatment (2mg) serving as model of short-term GH excess. Regarding long-term GH excess, RAS activity in 19 patients with active acromegaly (54[48-59]years, 52.6% females, IGF-I/ULN 2.8[2.3-3.3]) was compared to a cohort of 25 controls (39[32-47]years, 76% females). In 12 patients, measurements were re-conducted after successful treatment of acromegaly. Results One week of GH treatment increased IGF-I concentrations to 1.6±0.5 ULN and overall RAS activity, including angiotensin II levels (117.5 ±50.3pMol/L vs. 205.9 ±135.7pMol/L, p=0.03) and the surrogate of renin activity (PRA-S: 149.8 ±63.3pMol/L vs. 269.1 ±177.4pMol/L, p=0.03) alongside increased concentrations of insulin and C-peptide in healthy males. In contrast, patients with acromegaly showed lower concentrations of angiotensin II (47.2[33-145]pMol/L vs. 155.3[64-326]pMol/L, p=0.017), aldosterone (118[71-193]pMol/L vs. 227.8[165-305]pMol/L, p=0.009), and PRA-S(84.2[51-200]pMol/L vs. 230[85-403]pMol/L, p=0.032) despite higher mean arterial BP(105[99-115]mmHg vs. 91[85-97]mmHg, p< 0.001) compared to controls. Conclusion Short-term GH excess stimulates RAS activity which may be related to the increase in insulin and C-peptide. In contrast, RAS activity is down-regulated in long-term GH excess despite high BP.
| Reference Key |
openalex_W7164998476
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Clemens Baumgartner, Paul Fellinger, Anna Tosin, Anne Blanchard, Matthäus Metz, Oliver Domenig, Dunja van Ojen, A Luger, Greisa Vila, Alexandra Kautzky‐Willer, Michael Krebs, Philippe Chanson, Peter Kamenický, Peter Wolf |
| Journal | european journal of endocrinology |
| Year | 2026 |
| DOI |
10.1093/ejendo/lvag107
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.